News

Active Filters

A lung cancer precision medicine trial: Lung-MAP
Mar 31, 2022
The spring 2022 newsletter for Lung-MAP participating sites is now available.
S1314 at GU ASCO
Feb 15, 2022
Survival data from the first prospective, randomized biomarker validation trial in muscle-invasive bladder cancer presented at GU ASCO
Sex differences in risk of SAEs
Feb 14, 2022
Higher toxicity risk for women was known for chemotherapy, now also identified for immunotherapy and targeted therapy